Drug companies have a year to publish their data, or we’ll do it for them THE CONVERSATION by Tom Jefferson June 14, 2013 As a doctor it’s my job to prescribe lotions and potions. To do so, I read information about drug trials in books and medical journals to keep me up to speed on the […]
To every thing there is a season, and a time to every purpose under the heaven… Ecclesiastes 3:1, Corinthians II 6:2 In the story of every tension, there’s a time for reflection and understanding, and then there’s a time for action. But what action? The strange professor in my World Religion I Course had a […]
Tarnished Image? Psychiatrists Square Off Over A Nemeroff Lecture Pharmalot by Ed Silverman 6/12/2013 For the second time in little more than a year, Charles Nemeroff is the subject of protest by other psychiatrists. The latest instance involves an invitation by the Institute of Psychiatry, the leading center in the UK for psychiatric research, to […]
In objectively…, I was taken with the coordinated triad of the the cover story, an editorial [Workplace Depression: Personalize, Partner, or Pay the Price], and a STAR*D article [Increase in Work Productivity of Depressed Individuals With Improvement in Depressive Symptom Severity] in this month’s American Journal of Psychiatry – all directed towards the cost burden […]
I had missed this along the way, and it fills in a few blanks: A Soiled Phoenix Rises Mad in America by Philip Thomas, M.D. May 30, 2013 It has been a good time to bury controversy. With all eyes on Washington and the fallout from the publication of DSM-5, over here in England the […]
Back to psychiatric drugs, this time last year, I was in a conversation about the early days of drug discovery in psychiatry and was pointed to a study from 1959, A CONTROLLED TRIAL OF IMIPRAMINE IN TREATMENT OF DEPRESSIVE STATES [full text on-line]. That paper lead me to The History of Psychopharmacology and the CINP, […]
Irony abounds. The first archived post on this blog [an old, old piece of news…] was about the NSA spying back in December 2005. The old news was about whistle blower Katherine Gun’s leaking a memo about the NSA spying on the UN delegates in the lead in to our invasion of Iraq: Revealed: US […]
Decline in placebo-controlled trial results suggests new directions for comparative effectiveness research. by Olfson M and Marcus SC. Health Affairs. 2013 32[6]:1116-1125. The Affordable Care Act offers strong support for comparative effectiveness research, which entails comparisons among active treatments, to provide the foundation for evidence-based practice. Traditionally, a key form of research into the effectiveness […]
That men do not learn very much from the lessons of history is the most important of all the lessons of history. Aldous Huxley This week, a man died who had a profound effect on my close friends and the part of the world I live in. His name was Will Campbell [Rev. Will D. […]